Ontogenic changes of the control by phosphodiesterase‐3 and ‐4 of 5‐HT responses in porcine heart and relevance to human atrial 5‐HT4receptors
- 1 January 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 156 (2) , 237-249
Abstract
Background and purpose: Atrial inotropic responses to 5‐HT mediated through 5‐HT4receptors fade, presumably through phosphodiesterase (PDE) activity. We investigated the influence of a selective inhibitor of PDE3 (cilostamide) or of PDE4 (rolipram) on the fade of 5‐HT responses in atrial muscle.Experimental approach: 5‐HT responses were compared,ex vivo, on sinoatrial beating rate of newborn piglets, porcine atrial and ventricular force, and human atrial force. cAMP levels were assessed in piglet atrium.Key results: 5‐HT‐evoked sinoatrial tachycardia did not fade and was not potentiated by cilostamide (300 nmol·L−1) or rolipram (1 µmol·L−1). Inotropic responses to 5‐HT faded in atria from piglets, adolescent pigs and humans. Cilostamide reduced atrial fade of 5‐HT responses in adolescent pigs and humans but not in newborn piglets. Cilostamide disclosed 5‐HT ventricular responses in newborn, but not adolescent pigs. Rolipram reduced fade of atrial 5‐HT responses in newborn and adolescent pigs but not in humans. Concurrent cilostamide + rolipram abolished fade of 5‐HT responses in porcine left atria and facilitated ventricular 5‐HT responses, but did not reduce residual fade in human atrium in the presence of cilostamide. 5‐HT‐evoked increases in cAMP faded; fade was abolished by concurrent cilostamide + rolipram.Conclusions and implications: PDE3‐induced control of porcine 5‐HT responses differed in atrium and ventricle and changed with age. PDE3 and PDE4 jointly prevented fade of inotropic and cAMP responses to 5‐HT in porcine atrium. Unlike porcine atria, only PDE3 induced fade of 5‐HT responses in human atria.Keywords
This publication has 49 references indexed in Scilit:
- Inotropy and L‐type Ca2+current, activated by β1‐ and β2‐adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heartBritish Journal of Pharmacology, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Phosphodiesterase‐4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (−)‐adrenaline mediated through mouse cardiac β 1 ‐adrenoceptorsBritish Journal of Pharmacology, 2008
- Fading of 5‐HT4 receptor‐mediated inotropic responses to 5‐hydroxytryptamine is caused by phosphodiesterase activity in porcine atriumBritish Journal of Pharmacology, 2006
- Porcine left atrial and sinoatrial 5‐HT4receptor‐induced responses: fading of the response and influence of developmentBritish Journal of Pharmacology, 2006
- The effects of 5-HT receptor blockade and stimulation, during six hours of atrial fibrillationEP Europace, 2005
- Phospholamban: a crucial regulator of cardiac contractilityNature Reviews Molecular Cell Biology, 2003
- Effect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytesCardiovascular Research, 1998
- Effects of saterinone and its enantiomers R(+)-saterinone and S(−)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine heartsNaunyn-Schmiedeberg's Archives of Pharmacology, 1994
- Ontogeny of Adenylate Cyclase and Phosphodiesterase Activities in Swine TissuesNeonatology, 1977